["{\"step_by_step_thinking\": \"None of the provided documents relate to cabozantinib or Hepatocellular Carcinoma. The documents discuss various topics such as cisplatinum-induced neuropathy, thalidomide derivatives, treatment of glomerular diseases, iatrogenic reflux oesophagitis, and adrenocortical hyperactivity with disseminated malacoplakia. Therefore, it is not possible to determine the effectiveness of cabozantinib for Hepatocellular Carcinoma based on these documents.\", \"answer_choice\": \"B\"}"]